Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRelx Regulatory News (REL)

Share Price Information for Relx (REL)

Share Price is delayed by 15 minutes
Get Live Data
2,616.00    33.00 (1.28%)
Bid:
2,608.00
Ask:
2,610.00
Spread: 2.00 (0.077%)
Market Cap: £46.09b
REL Live PriceLast checked at - London Stock Exchange

Intraday Relx Share Chart

Non-Discretionary Share Buyback Programme

23 Mar 2026 10:02

RNS Number : 7026X
RELX PLC
23 March 2026
 

23 March 2026

RELX PLC

Announcement of Non-Discretionary Share Buyback Programme

RELX PLC (the "Company") announces in compliance with the UK and EU Market Abuse Regulations that it will implement an irrevocable, non-discretionary programme to repurchase its ordinary shares between 23 March 2026 and 22 April 2026 (the "Programme"), with a spend in this period of £350 million. This follows the successful completion of a £450 million non-discretionary programme on 20 March 2026. Both programmes are part of the £2.25 billion to be deployed on share buybacks in 2026, as announced on 12 February 2026.

The purpose of the Programme is to reduce the capital of the Company and it intends that shares purchased will be held in treasury.

Any share purchases will be made by the Company within certain pre-set parameters and in accordance with the general authority of the Company to repurchase shares granted by shareholders at the Company's Annual General Meeting held on 24 April 2025 which, taking into account shares purchased subsequent to this meeting, permits the Company to purchase no more than 136.4 million ordinary shares. Any share purchases effected by the Company will be in accordance with the UK and EU Market Abuse Regulations and Chapter 9 of the Listing Rules.

The Company has entered into an agreement with J.P. Morgan Securities plc (JPMS plc) under which it has issued instructions to JPMS plc to manage the Programme. JPMS plc will carry out the Company's instructions through the acquisition of ordinary shares in the Company for subsequent repurchase by the Company. JPMS plc will make its trading decisions under the Programme independently of, and uninfluenced by, the Company.

The Company also announces that any repurchases of its ordinary shares pursuant to the Programme, and any future repurchases after completion of the Programme, are expected to be announced on a weekly basis and in any event will be announced no later than the end of the seventh trading day following the date of the repurchase (in accordance with the Market Abuse Regulation (596/2014) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), the Commission Delegated Regulation (EU) 2016/1052 (as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019) and UK Listing Rule 9 (as amended by the UK Listing Rules (Notification of Purchases) Instrument dated 27 February 2026).

-ENDS-

Enquiries

Paul Sullivan (Investors)

Tel : +44 (0)20 7166 5751

Paul Abrahams (Media)

Tel : +44 (0)20 7166 5724

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEANDDASNKEEA
Date   Source Headline
1st Jun 202612:36 pmRNSTotal Voting Rights
1st Jun 202611:22 amRNSTransaction in Own Shares
1st Jun 202611:00 amRNS2025 Final Dividend Euro Equivalent
26th May 20264:27 pmRNSTransaction in Own Shares
26th May 20267:00 amRNSNon-Discretionary Share Buyback Programme
19th May 20263:03 pmRNSAdditional Listing
18th May 202611:43 amRNSTransaction in Own Shares
11th May 202612:54 pmRNSTransaction in Own Shares
5th May 20262:27 pmRNSTransaction in Own Shares
1st May 20262:25 pmRNSTotal Voting Rights
27th Apr 20262:48 pmRNSDirector/PDMR Shareholding
27th Apr 20262:23 pmRNSTransaction in Own Shares
27th Apr 202611:31 amRNSAdditional Listing
23rd Apr 20261:52 pmRNSResult of AGM
20th Apr 20262:06 pmRNSTransaction in Own Shares
13th Apr 202611:18 amRNSTransaction in Own Shares
7th Apr 202612:52 pmRNSTransaction in Own Shares
1st Apr 20263:14 pmRNSTotal Voting Rights
30th Mar 20264:20 pmRNSTransaction in Own Shares
26th Mar 20261:59 pmRNSAdditional Listing
23rd Mar 202610:02 amRNSNon-Discretionary Share Buyback Programme
20th Mar 20265:06 pmRNSTransaction in Own Shares
19th Mar 20265:10 pmRNSTransaction in Own Shares
18th Mar 20264:58 pmRNSTransaction in Own Shares
17th Mar 20265:11 pmRNSTransaction in Own Shares
16th Mar 20265:17 pmRNSTransaction in Own Shares
13th Mar 20265:35 pmRNSTransaction in Own Shares
12th Mar 20265:48 pmRNSTransaction in Own Shares
11th Mar 20264:57 pmRNSTransaction in Own Shares
11th Mar 20264:57 pmRNSTransaction in Own Shares
10th Mar 20265:03 pmRNSTransaction in Own Shares
9th Mar 20265:16 pmRNSTransaction in Own Shares
6th Mar 20265:37 pmRNSTransaction in Own Shares
6th Mar 202611:40 amRNSNotice of AGM
5th Mar 20265:46 pmRNSTransaction in Own Shares
4th Mar 20265:03 pmRNSTransaction in Own Shares
3rd Mar 20265:00 pmRNSTransaction in Own Shares
2nd Mar 20265:00 pmRNSTransaction in Own Shares
2nd Mar 20262:55 pmRNSTotal Voting Rights
27th Feb 20265:24 pmRNSTransaction in Own Shares
26th Feb 20265:36 pmRNSTransaction in Own Shares
25th Feb 20265:04 pmRNSTransaction in Own Shares
25th Feb 202612:28 pmRNSAdditional Listing
24th Feb 20264:58 pmRNSTransaction in Own Shares
23rd Feb 20265:11 pmRNSTransaction in Own Shares
20th Feb 20264:58 pmRNSTransaction in Own Shares
19th Feb 202611:54 amRNSAnnual Financial Report
17th Feb 20265:13 pmRNSTransaction in Own Shares
17th Feb 20267:30 amRNSDirector/PDMR Shareholding
13th Feb 20265:07 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.